Dacetuzumab | m-entrepreneurship.com

Product Name :
Dacetuzumab

Search keywords :
Dacetuzumab

drugId :
null

Target Vo:
Tumor necrosis factor receptor superfamily member 5

Target Vo Short Name :
CD40

Moa_Name:
Tumor necrosis factor receptor superfamily member 5 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Seagen Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Multiple Myeloma

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Acetyl-Histone H3 (Lys27) Rabbit mAb Purity
Odesivimab Autophagy
IL-18 Antibody: IL-18 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to IL-18. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts